Salesforce Partners with UChicago Medicine to Enhance Patient Support with AI Technology

Reuters
Jun 24
Salesforce Partners with UChicago Medicine to Enhance Patient Support with AI Technology

Salesforce Inc., a leader in AI-driven customer relationship management, has announced a new collaboration with UChicago Medicine to enhance patient support services. The academic health system is set to integrate Salesforce's Agentforce for Health into its non-clinical operations, enabling 24/7 access to personalized, self-service support for patients. This initiative aims to improve efficiency and patient care by automating tasks such as prescription refills and appointment scheduling. UChicago Medicine is also exploring further applications of AI technology to assist patients with logistical support and care navigation, ultimately allowing staff to focus on more complex patient needs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Salesforce Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250624764895) on June 24, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10